Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and Fetal Growth Restriction

tenofovir has been researched along with Fetal Growth Restriction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Acosta, S; Balogun, K; Guzman Lenis, MS; Mount, HT; Sarkar, A; Serghides, L1
Bunders, MJ; Cohen, S; Denneman, L; Godfried, MH; Kuijpers, TW; Nellen, JF; Pajkrt, D; Scherpbier, HJ; Smit, C; van de Plas, A; van Leeuwen, E; Weijsenfeld, AM1
Gatanaga, H; Gomibuchi, H; Hosokawa, S; Kikuchi, Y; Kinai, E; Oka, S1

Other Studies

3 other study(ies) available for tenofovir and Fetal Growth Restriction

ArticleYear
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.
    PloS one, 2020, Volume: 15, Issue:11

    Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir

2020
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.
    AIDS (London, England), 2016, 08-24, Volume: 30, Issue:13

    Topics: Anti-HIV Agents; Birth Weight; Child Development; Female; Fetal Development; Fetal Growth Retardation; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Tenofovir

2016
Blunted fetal growth by tenofovir in late pregnancy.
    AIDS (London, England), 2012, Oct-23, Volume: 26, Issue:16

    Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Bone Density; Female; Fetal Growth Retardation; Hepatitis B; HIV Seropositivity; Humans; Infant, Newborn; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Tenofovir

2012